Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft Rejection | 5 | 2014 | 1126 | 0.500 |
Why?
|
| B-Lymphocytes | 4 | 2014 | 771 | 0.340 |
Why?
|
| T-Lymphocytes | 5 | 2014 | 1316 | 0.320 |
Why?
|
| Organ Transplantation | 2 | 2014 | 298 | 0.320 |
Why?
|
| Skin Neoplasms | 5 | 2012 | 625 | 0.300 |
Why?
|
| Transplantation Tolerance | 2 | 2014 | 143 | 0.230 |
Why?
|
| Kidney Transplantation | 3 | 2014 | 882 | 0.210 |
Why?
|
| Antigen-Antibody Complex | 1 | 2014 | 89 | 0.210 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2014 | 25 | 0.210 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2014 | 42 | 0.210 |
Why?
|
| Antibodies, Bacterial | 1 | 2014 | 106 | 0.200 |
Why?
|
| Transplantation Immunology | 1 | 2013 | 83 | 0.200 |
Why?
|
| Interleukin-17 | 1 | 2014 | 110 | 0.200 |
Why?
|
| Communicable Diseases | 1 | 2014 | 69 | 0.200 |
Why?
|
| Bacterial Infections | 1 | 2014 | 185 | 0.190 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2014 | 290 | 0.180 |
Why?
|
| Neurothekeoma | 2 | 2012 | 5 | 0.180 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2014 | 259 | 0.170 |
Why?
|
| Placenta Diseases | 1 | 2019 | 13 | 0.160 |
Why?
|
| Bacteria | 1 | 2014 | 517 | 0.150 |
Why?
|
| Immune Tolerance | 1 | 2011 | 385 | 0.150 |
Why?
|
| Immunologic Memory | 2 | 2014 | 188 | 0.140 |
Why?
|
| Placenta | 1 | 2019 | 191 | 0.140 |
Why?
|
| Tissue Donors | 1 | 2011 | 542 | 0.140 |
Why?
|
| Drug Eruptions | 1 | 2018 | 35 | 0.140 |
Why?
|
| Inflammation | 1 | 2014 | 1068 | 0.140 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2551 | 0.120 |
Why?
|
| DNA, Bacterial | 2 | 1995 | 253 | 0.120 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 226 | 0.120 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 995 | 0.110 |
Why?
|
| Biomarkers, Tumor | 3 | 2012 | 1665 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 2 | 1995 | 930 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 2 | 1995 | 208 | 0.110 |
Why?
|
| Diagnosis, Differential | 7 | 2012 | 1619 | 0.100 |
Why?
|
| Tuberculosis, Cutaneous | 1 | 1992 | 2 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 173 | 0.090 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2012 | 13 | 0.090 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2012 | 14 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 162 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1431 | 0.090 |
Why?
|
| Indoles | 1 | 2013 | 317 | 0.090 |
Why?
|
| Mercury | 1 | 2011 | 12 | 0.090 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 2011 | 24 | 0.090 |
Why?
|
| Cranial Nerve Diseases | 1 | 2011 | 9 | 0.090 |
Why?
|
| Bowen's Disease | 1 | 2011 | 9 | 0.090 |
Why?
|
| Lipoma | 1 | 2011 | 27 | 0.090 |
Why?
|
| Paget Disease, Extramammary | 1 | 2011 | 8 | 0.090 |
Why?
|
| Neoplasms, Second Primary | 1 | 2013 | 247 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2013 | 338 | 0.090 |
Why?
|
| Ataxia | 1 | 2011 | 47 | 0.080 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2011 | 57 | 0.080 |
Why?
|
| Carcinoma in Situ | 1 | 2011 | 53 | 0.080 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2010 | 22 | 0.080 |
Why?
|
| Graft Survival | 2 | 2014 | 942 | 0.080 |
Why?
|
| Angiomatosis | 1 | 2009 | 4 | 0.080 |
Why?
|
| Calciphylaxis | 1 | 2009 | 4 | 0.080 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 2009 | 3 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2012 | 1829 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2013 | 211 | 0.080 |
Why?
|
| Collagen | 1 | 2011 | 307 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 126 | 0.080 |
Why?
|
| Arm | 1 | 2009 | 100 | 0.070 |
Why?
|
| Melanoma | 1 | 2013 | 497 | 0.070 |
Why?
|
| Humans | 21 | 2019 | 96127 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2009 | 176 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 100 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3651 | 0.070 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2008 | 166 | 0.060 |
Why?
|
| Adult | 12 | 2019 | 28718 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 466 | 0.060 |
Why?
|
| Male | 12 | 2018 | 45870 | 0.060 |
Why?
|
| Middle Aged | 10 | 2018 | 28363 | 0.050 |
Why?
|
| Laser Capture Microdissection | 1 | 2014 | 20 | 0.050 |
Why?
|
| Single-Chain Antibodies | 1 | 2014 | 21 | 0.050 |
Why?
|
| Animals | 4 | 2014 | 28945 | 0.050 |
Why?
|
| Bacterial Vaccines | 1 | 2014 | 45 | 0.050 |
Why?
|
| Female | 11 | 2019 | 50063 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 175 | 0.050 |
Why?
|
| Transplantation Chimera | 1 | 2013 | 84 | 0.050 |
Why?
|
| Rabbits | 1 | 2013 | 639 | 0.050 |
Why?
|
| Skin Transplantation | 1 | 2013 | 193 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2014 | 482 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1761 | 0.050 |
Why?
|
| Antibodies | 1 | 2013 | 357 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 1125 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 1023 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 287 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 810 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2014 | 9173 | 0.040 |
Why?
|
| Granuloma | 2 | 2018 | 65 | 0.040 |
Why?
|
| Mice | 2 | 2014 | 12562 | 0.040 |
Why?
|
| Lichenoid Eruptions | 1 | 2018 | 3 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 847 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2013 | 812 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 301 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 3490 | 0.030 |
Why?
|
| Aged | 5 | 2013 | 20964 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 188 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2012 | 3974 | 0.030 |
Why?
|
| Esophagitis | 1 | 1996 | 43 | 0.030 |
Why?
|
| Polyps | 1 | 1996 | 26 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 481 | 0.030 |
Why?
|
| Erythema Induratum | 1 | 1995 | 1 | 0.030 |
Why?
|
| Leg Dermatoses | 1 | 1995 | 7 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2018 | 286 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2059 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1958 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2014 | 77 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 3147 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 1996 | 346 | 0.030 |
Why?
|
| Risk Factors | 1 | 2014 | 5960 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 270 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 336 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 3240 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 348 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 855 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2013 | 302 | 0.020 |
Why?
|
| Adolescent | 3 | 2012 | 9896 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2011 | 134 | 0.020 |
Why?
|
| Skin | 2 | 2009 | 605 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2010 | 46 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 163 | 0.020 |
Why?
|
| Ki-1 Antigen | 1 | 2009 | 19 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 259 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 7232 | 0.020 |
Why?
|
| Crohn Disease | 1 | 1996 | 806 | 0.020 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2009 | 109 | 0.020 |
Why?
|
| Young Adult | 2 | 2012 | 7025 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1220 | 0.020 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2008 | 12 | 0.020 |
Why?
|
| Genital Neoplasms, Male | 1 | 1988 | 11 | 0.020 |
Why?
|
| Scrotum | 1 | 1988 | 18 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 156 | 0.020 |
Why?
|
| Hemangioma | 1 | 1988 | 65 | 0.020 |
Why?
|
| Leiomyosarcoma | 1 | 1988 | 49 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 527 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 10286 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 4671 | 0.010 |
Why?
|
| Disease Progression | 1 | 2008 | 1568 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 1351 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 2794 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 2579 | 0.010 |
Why?
|
| Child | 1 | 2012 | 7626 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 1996 | 72 | 0.010 |
Why?
|
| Tuberculin Test | 1 | 1995 | 9 | 0.010 |
Why?
|
| Fixatives | 1 | 1995 | 12 | 0.010 |
Why?
|
| Microtomy | 1 | 1995 | 10 | 0.010 |
Why?
|
| Panniculitis | 1 | 1995 | 11 | 0.010 |
Why?
|
| Formaldehyde | 1 | 1995 | 53 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 1995 | 79 | 0.010 |
Why?
|
| Vasculitis | 1 | 1995 | 40 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1995 | 62 | 0.010 |
Why?
|
| Necrosis | 1 | 1995 | 210 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 548 | 0.010 |
Why?
|
| Radiography | 1 | 1996 | 826 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1988 | 328 | 0.000 |
Why?
|